Viral Infections

  • Author: Jin S. Suh, MD, FACP; Humberto R. Jimenez, PharmD, BCPS, AAHIVP (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 8/1/21 (What's New)


  • Several studies have shown that treatment of HSV-2 in coinfected patients may reduce their HIV-1 RNA modestly or reduce the risk of clinical progression, excluding patients on ART
  • However, because anti-HSV therapies do not prevent HIV transmission, they should not be used to delay HIV progression in the place of ART when ART is available[Celum 2010; CDC OI]

Action required